When Big Pharma Walks Away: What Abandoned Patents Reveal About Pipeline Priorities
In the high-stakes world of pharmaceutical innovation, the departure of a major player from a promising drug development project often signals more than just a strategic retreat—it reveals underlying shifts in industry priorities, market dynamics, and …
When Big Pharma Walks Away: What Abandoned Patents Reveal About Pipeline Priorities Read Post »
